VIRP Share Price

Open 128.65 Change Price %
High 128.85 1 Day -0.90 -0.70
Low 127.20 1 Week 0.20 0.16
Close 127.75 1 Month -14.35 -10.10
Volume 3396 1 Year -66.10 -34.10
52 Week High 221.85
52 Week Low 127.00
VIRP Important Levels
Resistance 2 129.28
Resistance 1 128.65
Pivot 127.93
Support 1 126.85
Support 2 126.22
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
ALEUP 0.28 7.69%
BRS 12.00 0.00%
More..
EPA France Top Gainers Stocks
ALALO 0.03 50.00%
LTAN 2.79 32.86%
ALADO 0.05 25.00%
ALMAS 0.85 23.19%
MLDEX 0.37 19.35%
AB 12.24 17.24%
AB 12.24 17.24%
APAM 33.78 15.72%
APAM 33.78 15.72%
EOS 1.06 15.22%
More..
EPA France Top Losers Stocks
MLDYN 3.63 -18.79%
MLGEO 0.30 -16.67%
AVT 0.05 -16.67%
AVT 0.05 -16.67%
AVT 0.05 -16.67%
AVT 0.05 -16.67%
ALDV 0.08 -11.11%
FIPP 0.14 -6.67%
FIPP 0.14 -6.67%
NEO 26.85 -5.36%
More..

Virbac (EPA: VIRP)

VIRP Technical Analysis 5
As on 2nd Dec 2016 VIRP Share Price closed @ 127.75 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 162.39 & Strong Sell for SHORT-TERM with Stoploss of 143.35 we also expect STOCK to react on Following IMPORTANT LEVELS.
VIRP Target for December
1st Target up-side 138.5
2nd Target up-side 145.89
3rd Target up-side 153.28
1st Target down-side 117.4
2nd Target down-side 110.01
3rd Target down-side 102.62
VIRP Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.virbac.com
VIRP Address
VIRP
13e rue LID - BP 27
Carros, 06511
France
Phone: 33 4 92 08 71 00
Fax: 33 4 92 08 71 65
Interactive Technical Analysis Chart Virbac ( VIRP EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Virbac
VIRP Business Profile
Virbac SA develops, manufactures, and sells vaccines and medicines to prevent and treat pathologies for companion and food-producing animals in France, the rest of Europe, North America, Latin America, Africa, the Middle East, Asia, and the Pacific region. The company’s products comprise Bovidec to treat bovine viral diarrhea; Browse plus, a nutritional supplement; CaniLeish to protect against canine leishmaniosi; Deltanil for use in cattle and sheep as a topical application; Effi pro for flea and tick infestations in dogs and cats; Epi-Otic, a ear cleanser for dogs and cats; Flukazole C, a internal parasiticide in cattle and sheep for benzimidazole-sensitive worms; and Fortius, a injectable antibiotic. Its products also include Cydectine, a moxidectin-based parasiticide; Iverhart, a chewable tablet for use in dogs to prevent canine heartworm, roundworms, hookworms, and tapeworms; Luminal to treat epilepsy in dogs; Maxflor for respiratory diseases of bacterial origin in cattle and pigs; Milteforan, a miltefosine-based oral treatment; and Multibio for digestive, respiratory, and genitourinary diseases. In addition, the company offers Multimin, a trace element injectable supplement; Nutri plus gel, an oral paste-based food supplement; Ostovet, a food supplement for cattle; Penclox for mastitis in dairy cattle; Prodose, an anthelmintic; Pulmodox for respiratory diseases in pigs and poultry; Rabigen mono, a monovalent and multi-dose rabies vaccine; Rabigen SAG2, an oral rabies vaccine; Super Mastidol to prevent and treat mastitis in dairy cattle; Suprelorin for temporary infertility in male dogs; Virbamec, a ivermectin-based parasiticide; Vet complex, a specialised petfood; Veterin for swine, poultry, and salmonids; Vetflurane, a isoflurane-based general anaesthetic; Vimeral, a food supplement; and Zoletil, a multi-species general anaesthetic. Further, it provides contract manufacturing services. Virbac SA was founded in 1968 and is headquartered in Carros, France.